An innovation in the development of antibiotics at the Kim Lewis Lab at Northeastern University is generating global excitement. **Dr. Kim Lewis** explains how bacterial resistance to our current antibiotics has reached a critical point. He describes the traditional method of developing antibiotics and then the unique method he and his colleagues pioneered that has led to a major breakthrough. The first result is a new antibiotic, teixobactin, which is in the early stages of testing, but is already making headlines around the world.
Kim Lewis is a University Distinguished Professor and the Director of the Antimicrobial Discovery Center at Northeastern University. The focus of his research is on antimicrobial drug tolerance and drug discovery.